MELK is over-expressed in these cancers, and high expression of MELK is associated with poor patient prognosis (Wang et al., 2014; Pickard et al., 2009; Phillips et al., 2006; Ryu et al., 2007; Gray et al., 2005). This evidence concerns the gene MELK and cancer.